If SAA-stimulation leads to production of IL-6 by a dysfunctional endothelium, then this interleukin may induce the production of additional SAA, thereby establishing an autocrine loop and effectively exacerbating endothelial dysfunction. The gene discussed is IL6; the disease is endothelial dysfunction.